Spexis AG
Nicolas Desjonqueres has extensive experience in the field of chemistry, with a focus on peptide and macrocycle chemistry. Currently working as a Senior Scientist at Spexis AG since June 2008, Nicolas is responsible for improving and developing automated parallel peptide synthesis platforms. Prior to this, Nicolas worked at Polyphor Ltd from December 2000 to April 2008, where Nicolas managed the production of small molecules libraries. With a postgraduate diploma in combinatorial chemistry from the University of Montpellier and a Master's degree in Organic chemistry from Université Versailles St Quentin en Yvelines, Nicolas has a strong educational background to support their impressive career in the field of chemistry.
This person is not in any offices
Spexis AG
Polyphor is a Swiss Pharma company focusing on the discovery and development of macrocycle drugs addressing high unmet medical needs.Polyphor was founded in 1996 and is a clinical stage, privately held Swiss specialty pharma company, based in Allschwil near Basel. It focuses on the development of macrocycle drugs that address antibioticresistance and severe respiratory diseases.